NAVERIS

NAVERIS is a biotechnology company focused on the early detection of viral cancers through innovative technologies. Their flagship product, NavDx®, is a highly sensitive liquid biopsy that enables earlier identification and monitoring of HPV-related cancers compared to traditional methods. With a mission to improve patient outcomes and transform cancer detection, Naveris leverages proprietary technology for non-invasive blood tests that provide real-time insights into cancer recurrence and treatment responses.